These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 35543133
21. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation. Noseworthy PA, Van Houten HK, Krumholz HM, Kent DM, Abraham NS, Graff-Radford J, Alkhouli M, Henk HJ, Shah ND, Gersh BJ, Friedman PA, Holmes DR, Yao X. J Am Heart Assoc; 2022 Oct 04; 11(19):e027001. PubMed ID: 36172961 [Abstract] [Full Text] [Related]
23. CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study. Kim TH, Yang PS, Kim D, Yu HT, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH. Stroke; 2017 Nov 04; 48(11):2984-2990. PubMed ID: 28939672 [Abstract] [Full Text] [Related]
26. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation. Hilkens NA, Algra A, Greving JP. Stroke; 2017 Nov 04; 48(11):3142-3144. PubMed ID: 28931618 [Abstract] [Full Text] [Related]
27. Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease. Chang SH, Wu CV, Yeh YH, Kuo CF, Chen YL, Wen MS, See LC, Huang YT. Am J Med; 2019 Nov 04; 132(11):1335-1343.e6. PubMed ID: 31278930 [Abstract] [Full Text] [Related]
30. Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation. Wang CL, Wu VC, Huang YT, Chen YL, Chu PH, Kuo CF, Wen MS, Chang SH. J Thromb Thrombolysis; 2021 Jan 04; 51(1):58-66. PubMed ID: 32409936 [Abstract] [Full Text] [Related]
33. Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment. Lin SY, Liao YT, Tang SC, Lin CC, Wang CC. J Am Heart Assoc; 2024 Feb 06; 13(3):e032454. PubMed ID: 38293918 [Abstract] [Full Text] [Related]
36. Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. Komen JJ, Pottegård A, Mantel-Teeuwisse AK, Forslund T, Hjemdahl P, Wettermark B, Hallas J, Olesen M, Bennie M, Mueller T, Carragher R, Karlstad Ø, Kjerpeseth LJ, Klungel OH. Eur Heart J; 2022 Oct 07; 43(37):3528-3538. PubMed ID: 35265981 [Abstract] [Full Text] [Related]
37. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation. Park CW, Nam HS, Heo JH, Park HJ, Choi JK, Lee HS, Na HK, Kim YD. J Stroke Cerebrovasc Dis; 2020 Sep 07; 29(9):105025. PubMed ID: 32807440 [Abstract] [Full Text] [Related]
38. Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry. Yoshimoto T, Toyoda K, Ihara M, Inoue H, Yamashita T, Suzuki S, Akao M, Atarashi H, Ikeda T, Okumura K, Koretsune Y, Shimizu W, Tsutsui H, Hirayama A, Yasaka M, Maruyama H, Teramukai S, Kimura T, Morishima Y, Takita A, Yamaguchi T. Stroke; 2022 Aug 07; 53(8):2549-2558. PubMed ID: 35440169 [Abstract] [Full Text] [Related]
39. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. JAMA; 2002 Nov 20; 288(19):2441-8. PubMed ID: 12435257 [Abstract] [Full Text] [Related]
40. Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis. Cavallari I, Verolino G, Romano S, Patti G. Thromb Haemost; 2020 Feb 20; 120(2):314-321. PubMed ID: 31785599 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]